May 17, 2020

FBI Warning Highlights Healthcare Sector’s Vulnerability to Cyber Attacks

Health IT
United States Healthcare
Security Breach
FBI
Admin
2 min
The FBI has issued several alerts within the past few months, the most recent being in April, warning the healthcare industry that its systems were too lax compared with other sectors.
In a private message sent to health care providers, the FBI warned health care industry companies of being targeted by hackers and advised them to take...

In a private message sent to health care providers, the FBI warned health care industry companies of being targeted by hackers and advised them to take immediate measures to defend their systems.

The alert comes after the attack on U.S. hospital group Community Health Systems Inc. that resulted in the theft of millions of patient records.

“The FBI has observed malicious actors targeting healthcare related systems, perhaps for the purpose of obtaining Protected Healthcare Information (PHI) and/or Personally Identifiable Information (PII),” the agency said in a “Flash” alert obtained by Reuters.

“These actors have also been seen targeting multiple companies in the healthcare and medical device industry typically targeting valuable intellectual property, such as medical device and equipment development data,” the document stated.

According to the news service, the FBI and department of Homeland Security periodically release alerts to provide U.S. businesses with technical details and other information they can use to either prevent or identify cyber attacks.

The FBI has issued several alerts within the past few months, the most recent being in April, warning the industry that its systems were too lax compared with other sectors.

On Monday, Aug. 18, Community Health disclosed the attack, saying stolen data included patient names, addresses, birth dates and Social Security numbers. In its filing with the U.S. Securities and Exchange Commission, the group revealed that its security was bypassed and attackers were able to copy data. A China-based attacker is believed to be responsible for the intrusion.

“In this instance the data transferred was non-medical patient identification data related to the Company’s physician practice operations and affected approximately 4.5 million individuals who, in the last five years, were referred for or received services from physicians affiliated with the Company,” the filing stated.

“The [FBI] warning is just bringing additional awareness to a healthcare market that has really reflected the industry's lack of awareness to date of the cyber threat they face,” Mick Coady, PricewaterhouseCoopers (PwC) Health Information Privacy and Security Partner told Dark Reading. “Healthcare is where the financial industry was 10- to 12 years ago in terms of IT security.”

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article